Literature DB >> 32574562

NAD+ Regeneration Rescues Lifespan, but Not Ataxia, in a Mouse Model of Brain Mitochondrial Complex I Dysfunction.

Gregory S McElroy1, Colleen R Reczek1, Paul A Reyfman1, Divakar S Mithal2, Craig M Horbinski3, Navdeep S Chandel4.   

Abstract

Mitochondrial complex I regenerates NAD+ and proton pumps for TCA cycle function and ATP production, respectively. Mitochondrial complex I dysfunction has been implicated in many brain pathologies including Leigh syndrome and Parkinson's disease. We sought to determine whether NAD+ regeneration or proton pumping, i.e., bioenergetics, is the dominant function of mitochondrial complex I in protection from brain pathology. We generated a mouse that conditionally expresses the yeast NADH dehydrogenase (NDI1), a single enzyme that can replace the NAD+ regeneration capability of the 45-subunit mammalian mitochondrial complex I without proton pumping. NDI1 expression was sufficient to dramatically prolong lifespan without significantly improving motor function in a mouse model of Leigh syndrome driven by the loss of NDUFS4, a subunit of mitochondrial complex I. Therefore, mitochondrial complex I activity in the brain supports organismal survival through its NAD+ regeneration capacity, while optimal motor control requires the bioenergetic function of mitochondrial complex I.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Leigh syndrome; NAD; ataxia; metabolism; microglia; mitochondria; mitochondrial complex I; mitochondrial disease; neurodegeneration; neurometabolism

Year:  2020        PMID: 32574562      PMCID: PMC7415718          DOI: 10.1016/j.cmet.2020.06.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  27 in total

1.  Isolation and culture of mouse cortical astrocytes.

Authors:  Sebastian Schildge; Christian Bohrer; Kristina Beck; Christian Schachtrup
Journal:  J Vis Exp       Date:  2013-01-19       Impact factor: 1.355

2.  Expression of the yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan independently of dietary restriction.

Authors:  Alberto Sanz; Mikko Soikkeli; Manuel Portero-Otín; Angela Wilson; Esko Kemppainen; George McIlroy; Simo Ellilä; Kia K Kemppainen; Tea Tuomela; Matti Lakanmaa; Essi Kiviranta; Rhoda Stefanatos; Eric Dufour; Bettina Hutz; Alba Naudí; Mariona Jové; Akbar Zeb; Suvi Vartiainen; Akemi Matsuno-Yagi; Takao Yagi; Pierre Rustin; Reinald Pamplona; Howard T Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-30       Impact factor: 11.205

3.  Mitochondrial complex III stabilizes complex I in the absence of NDUFS4 to provide partial activity.

Authors:  Maria Antonietta Calvaruso; Peter Willems; Mariël van den Brand; Federica Valsecchi; Shane Kruse; Richard Palmiter; Jan Smeitink; Leo Nijtmans
Journal:  Hum Mol Genet       Date:  2011-09-28       Impact factor: 6.150

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Fatal breathing dysfunction in a mouse model of Leigh syndrome.

Authors:  Albert Quintana; Sebastien Zanella; Henner Koch; Shane E Kruse; Donghoon Lee; Jan M Ramirez; Richard D Palmiter
Journal:  J Clin Invest       Date:  2012-06-01       Impact factor: 14.808

6.  mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.

Authors:  Simon C Johnson; Melana E Yanos; Ernst-Bernhard Kayser; Albert Quintana; Maya Sangesland; Anthony Castanza; Lauren Uhde; Jessica Hui; Valerie Z Wall; Arni Gagnidze; Kelly Oh; Brian M Wasko; Fresnida J Ramos; Richard D Palmiter; Peter S Rabinovitch; Philip G Morgan; Margaret M Sedensky; Matt Kaeberlein
Journal:  Science       Date:  2013-11-14       Impact factor: 47.728

7.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

8.  Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.

Authors:  Michele Ferrari; Isha H Jain; Olga Goldberger; Emanuele Rezoagli; Robrecht Thoonen; Kai-Hung Cheng; David E Sosnovik; Marielle Scherrer-Crosbie; Vamsi K Mootha; Warren M Zapol
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

9.  Defined neuronal populations drive fatal phenotype in a mouse model of Leigh syndrome.

Authors:  Irene Bolea; Alejandro Gella; Elisenda Sanz; Patricia Prada-Dacasa; Fabien Menardy; Angela M Bard; Pablo Machuca-Márquez; Abel Eraso-Pichot; Guillem Mòdol-Caballero; Xavier Navarro; Franck Kalume; Albert Quintana
Journal:  Elife       Date:  2019-08-12       Impact factor: 8.140

10.  The structure of the yeast NADH dehydrogenase (Ndi1) reveals overlapping binding sites for water- and lipid-soluble substrates.

Authors:  Momi Iwata; Yang Lee; Tetsuo Yamashita; Takao Yagi; So Iwata; Alexander D Cameron; Megan J Maher
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

View more
  19 in total

Review 1.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

Review 2.  Targeting adaptive cellular responses to mitochondrial bioenergetic deficiencies in human disease.

Authors:  Christopher F Bennett; Conor T Ronayne; Pere Puigserver
Journal:  FEBS J       Date:  2021-09-12       Impact factor: 5.542

3.  Isoflurane inhibition of endocytosis is an anesthetic mechanism of action.

Authors:  Sangwook Jung; Pavel I Zimin; Christian B Woods; Ernst-Bernhard Kayser; Dominik Haddad; Colleen R Reczek; Ken Nakamura; Jan-Marino Ramirez; Margaret M Sedensky; Philip G Morgan
Journal:  Curr Biol       Date:  2022-06-09       Impact factor: 10.900

Review 4.  Principles and functions of metabolic compartmentalization.

Authors:  Liron Bar-Peled; Nora Kory
Journal:  Nat Metab       Date:  2022-10-20

Review 5.  Genetically encoded tools for measuring and manipulating metabolism.

Authors:  Mangyu Choe; Denis V Titov
Journal:  Nat Chem Biol       Date:  2022-04-28       Impact factor: 16.174

Review 6.  Mitochondrial pathways in human health and aging.

Authors:  Rebecca Bornstein; Brenda Gonzalez; Simon C Johnson
Journal:  Mitochondrion       Date:  2020-07-30       Impact factor: 4.160

7.  NAD+ metabolism controls growth inhibition by HIF1 in normoxia and determines differential sensitivity of normal and cancer cells.

Authors:  Michal W Luczak; Casey Krawic; Anatoly Zhitkovich
Journal:  Cell Cycle       Date:  2021-08-12       Impact factor: 5.173

8.  Metformin treatment of the C9orf72 ALS/FTD mouse: Almost too good for words.

Authors:  Michael Rosbash
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-29       Impact factor: 11.205

Review 9.  Organization of the Respiratory Supercomplexes in Cells with Defective Complex III: Structural Features and Metabolic Consequences.

Authors:  Michela Rugolo; Claudia Zanna; Anna Maria Ghelli
Journal:  Life (Basel)       Date:  2021-04-17

10.  Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation.

Authors:  Hongxu Xian; Yuan Liu; Alexandra Rundberg Nilsson; Raphaella Gatchalian; Timothy R Crother; Warren G Tourtellotte; Yi Zhang; German R Aleman-Muench; Gavin Lewis; Weixuan Chen; Sarah Kang; Melissa Luevanos; Dorit Trudler; Stuart A Lipton; Pejman Soroosh; John Teijaro; Juan Carlos de la Torre; Moshe Arditi; Michael Karin; Elsa Sanchez-Lopez
Journal:  Immunity       Date:  2021-06-10       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.